We saw mixed action in biotech and healthcare stocks today. We saw some bigger name pharmaceutical stocks slide, such as PFE, which fell persistently after the open, trading more than -2.00% lower during the session. Meanwhile, ENDP was up sharply on news that the FDA is considering restricting the manufacturing of three substances by companies that produce compounded medications in bulk. One of these substances is Vasopressin. The news is considered bullish for ENDP since the company utilizes it as an active ingredient in its FDA approved blood pressure drug Vasostrict. Here’s a recap of what happened.